Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Georgia Fogden-King's Articles

Fuel3D to establish new headquarters on The Oxford Science Park

Company to be first occupier of the Park’s state-of-the-art Schrödinger Building

Celebrating two years in business!

Arcinova was launched in February 2016, following the acquisition of the Covance site in Alnwick, by Arc Trinova Limited, a new company formed by Ian Shott and Paul Ryan, owners of Shott Trinova LLP.

Oxford 3D bioprinting company OxSyBio secures £10m in funding

OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.

Immunotherapy Used to Treat Aggressive Colon Tumors

Acquisition establishes an Asia Pacific Headquarters for PCI

 

Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccines

Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 million investment round.

High Throughput PARP Screening Assay

AMSBIO is a specialist life science company offering an extensive portfolio of Poly (ADP-ribose) polymerase (PARP) isozymes.  In addition, AMSBIO also offer assay kits, inhibitors, recombinant histone substrates and screening / profiling services for over 10 different PARP’s.

Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission

Collaborations and commercial contracts to advance company’s growth and role in Asia

Novel Microfluidic Platform for Cancer Research

The new platform combines microfluidic lab-on-a-chip technology with physiologically relevant 3D spheroids to enable formation and long-term culture of 3D multicellular tumors / organoids for drug screening and individualized chemosensitivity testing

CPI Annual Review- 2017

CPI is an independent technology innovation centre that translates ideas, research and knowledge into commercial business propositions by helping companies to develop, prove, prototype and scale up new products and processes at reduced risk.

Isogenic Panels of Neuronal iPSC Derivatives

AMSBIO announces the launch of a new range of induced pluripotent stem cell (iPSC) derived neural stem cells (NSCs) and neural lineage progenitors.

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.